The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

The “hidden experiment”: percutaneous vs. surgical cut-down for transfemoral transcatheter aortic valve implantation

EuroIntervention 2017;12:1925-1926. DOI: 10.4244/EIJV12I16A313

1. Department of Medicine, Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada; 2. Department of Cardiology, Bern University Hospital, Bern, Switzerland


Exactly 10 years ago, the Rotterdam group reported on the first true percutaneous implantation of the 18 Fr CoreValve Revalving System (Medtronic, Minneapolis, MN, USA) by the combined use of ultrasound-guided vascular access, Prostar® XL (Abbott Vascular, Santa Clara, CA, USA), and TandemHeart™ (Cardiac Assist Inc., Pittsburgh, PA, USA) support1. Possibly overlooked, this transformative moment was the embodiment of the much-heralded movement of TAVI towards a true “PCI-like” intervention. As a result of the downsizing of delivery catheters and the implementation of best practice guidelines, a percutaneous transfemoral approach is now used in more than 90% of patients undergoing TAVI at most ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Iteration of second-generation drug-eluting stents: the missing piece of evidence